MedTrace Logo

rTMS in Treatment Resistant Depression

NCT02080507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-05-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the safety and efficacy of rTMS as an alternative treatment to ECT. The study will also provide data for a power analysis to support a larger clinical trial if there is evidence of a clinically relevant treatment effect.

Conditions

Interventions

DEVICE

Active Neuronetics rTMS stimulator

In the active group, magnetic power output will be delivered to the subject through the coils.

DEVICE

Inactive Neuronetics rTMS stimulator

In the inactive group, no magnetic power output will be delivered to the subject through the coils.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • William M McDonald, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02080507 on ClinicalTrials.gov